Sunil Hingorani, MD, PhD

Nancy Armitage Pancreas Cancer Presidential Chair
Director, Pancreatic Cancer Center of Excellence
Professor, UNMC Division of Oncology & Hematology

Sunil Hingorani, MD, PhD, a highly accomplished and internationally recognized pancreas cancer researcher and clinician. He is the inaugural recipient of the Nancy Armitage Pancreas Cancer Clinical Research Presidential Chair and the first director of the Pancreatic Cancer Center of Excellence at UNMC and Nebraska Medicine.

At UNMC, Dr. Hingorani conducts and oversees a comprehensive translational research program, while also leading development of a real-time, multi-disciplinary clinic for pancreas cancer patients at Nebraska Medicine.

Dr. Hingorani’s research success is well-documented. He helped develop the first mouse models to accurately mimic human pancreas cancer from its precancerous inception to its advanced stages. Dr. Hingorani has used these models to identify genetic events, signaling pathways and collaborating cell types that contribute to the aggressiveness of ductal adenocarcinoma, the most common and deadly form of pancreas cancer. Dr. Hingorani has made multiple breakthroughs in his lab that have informed the course of his latest phase of research, as well as that of others, and his lab is testing these ideas in a novel Murine Clinical Trials Program to identify those strategies most likely to succeed in patients.